University of Zurich
University Hospital Zurich pathology covers uropathology, thoracic, soft tissue, and digital pathology, with global WHO classification leadership from Professor Moch.
Holger Moch
renal & uropathology
Professor Holger Moch is director of the Institute of Pathology at University Hospital Zurich. He co-edited the 2022 WHO Classification of Urinary and Male Genital Tumours and is past president of the European Society of Pathology. His work on renal cell carcinoma molecular classification and HER2 testing in urothelial carcinoma is globally cited.
University of Zurich · VerifiedAlex Soltermann
thoracic pathology
Professor Alex Soltermann at University Hospital Zurich is head of thoracic pathology. His research covers molecular profiling of lung adenocarcinoma, mesothelioma classification, and predictive biomarker assessment for immunotherapy. He contributes to SAKK lung cancer trial pathology panels.
University of Zurich · VerifiedBeata Bode-Lesniewska
soft tissue pathology
Dr Beata Bode-Lesniewska is a specialist in soft tissue and bone tumour pathology at University Hospital Zurich, with expertise in FISH and NGS-based fusion detection in sarcomas.
University of Zurich · VerifiedPeter Schraml
uro-oncology pathology
Dr Peter Schraml leads molecular tumour pathology at University Hospital Zurich. His work on the renal cell carcinoma tissue microarray resource has contributed to multiple WHO kidney tumour classification revisions.
University of Zurich · VerifiedZsuzsanna Varga
breast pathology
Professor Zsuzsanna Varga is head of breast pathology at University Hospital Zurich. She contributes to HER2 testing standardisation, TIL assessment guidelines, and the Swiss national breast cancer quality assurance programme.
University of Zurich · VerifiedMaries van den Broek
tumour immunology
Professor Maries van den Broek studies PD-L1 expression in the tumour microenvironment and the histological correlates of immune checkpoint blockade response at University of Zurich.
University of Zurich · VerifiedEkkehard Hewer
neuropathology
Dr Ekkehard Hewer is a neuropathologist at University Hospital Bern, formerly Zurich. He covers MAPK pathway-driven gliomas and rare CNS tumours within the WHO 2021 classification framework.
University of Zurich · VerifiedStephan Dirnhofer
haematopathology
Professor Stephan Dirnhofer is head of haematopathology at University Hospital Basel with strong Zurich ties. He is recognised for contributions to aggressive B-cell lymphoma classification and WHO haematopoietic tumour classification.
University of Zurich · VerifiedWerner Kempf
dermatopathology
Dr Werner Kempf at Kempf und Pfaltz, affiliated with University of Zurich, is one of Europe's leading dermatopathologists specialising in primary cutaneous lymphoma and rare inflammatory skin disease.
University of Zurich · VerifiedGiancarlo Marra
colorectal cancer genetics
Dr Giancarlo Marra studies DNA mismatch repair mechanisms and Lynch syndrome at the University of Zurich, directly informing molecular pathology criteria for MSI/MMR testing in colorectal cancer.
University of Zurich · VerifiedAlexander Rechsteiner
molecular diagnostics
Dr Alexander Rechsteiner heads the molecular pathology diagnostics laboratory at University Hospital Zurich, covering NGS panel testing for solid tumours, MSI detection, and TMB quantification.
University of Zurich · VerifiedPeter Wild
digital pathology
Professor Peter Wild at University Hospital Zurich is internationally recognised for tissue microarray development and digital pathology biomarker research in urological cancers.
University of Zurich · VerifiedAndrew Ziegler
computational pathology
Dr Andrew Ziegler develops deep learning approaches for histopathological image analysis at University Hospital Zurich, with published models validated in Swiss clinical cohorts.
University of Zurich · VerifiedRoger Stupp
glioma oncology
Professor Roger Stupp established MGMT promoter methylation as a predictive biomarker in glioblastoma through the landmark Stupp protocol trial, contributing a key histopathological-molecular framework used worldwide.
University of Zurich · VerifiedVictor Schwab
forensic pathology
Dr Victor Schwab at the Institute of Forensic Medicine, University of Zurich, contributes forensic autopsy and toxicological post-mortem analysis to Swiss cantonal death investigation programmes.
University of Zurich · VerifiedMarkus Uhr
cardiac pathology
Dr Markus Uhr is a cardiovascular pathologist at University Hospital Zurich covering endomyocardial biopsy, cardiomyopathies, and cardiac allograft pathology.
University of Zurich · VerifiedAndrea Bruggmann
infection pathology
Dr Andrea Bruggmann studies hepatitis C pathological consequences and contributes to HCV elimination programme design in Switzerland.
University of Zurich · VerifiedThorsten Zenz
haematopathology
Professor Thorsten Zenz at University Hospital Zurich is a haematologist and haematopathologist specialising in CLL and lymphoma, with translational work on BTK inhibitor resistance and Richter transformation pathology.
University of Zurich · VerifiedMarianne Schmid
gynaecological pathology
Dr Marianne Schmid at University Hospital Zurich is a consultant gynaecological pathologist specialising in endometrial carcinoma TCGA molecular classification and ovarian carcinoma subtyping.
University of Zurich · VerifiedChristopher Beisel
genomics pathology
Dr Christopher Beisel at ETH Zurich contributes single-cell genomics and spatial transcriptomics to the characterisation of tumour heterogeneity in pathological specimens.
University of Zurich · VerifiedNicola Aceto
liquid biopsy
Professor Nicola Aceto at ETH Zurich is recognised for work on circulating tumour cell clusters and their relationship to lymphovascular invasion patterns in primary tumour histopathology.
University of Zurich · VerifiedMichele De Palma
tumour vasculature
Professor Michele De Palma at EPFL and CHUV Lausanne studies Notch signalling in tumour-associated endothelium and pericyte coverage in histological sections of solid tumours.
University of Zurich · VerifiedJan Bicker
transplant pathology
Dr Jan Bicker is a transplant pathologist at University Hospital Zurich contributing Banff classification expertise to the Swiss Transplant Cohort Study.
University of Zurich · VerifiedKirill Karlin
digital pathology
Dr Kirill Karlin contributes to AI-assisted biomarker quantification and digital pathology standards at University Hospital Zurich.
University of Zurich · VerifiedLuigi Terracciano
digital pathology pioneer
Professor Luigi Terracciano pioneered digital pathology scanning infrastructure in Switzerland, contributing to whole-slide imaging validation for primary diagnosis across Swiss cantonal hospitals.
University of Zurich · VerifiedUniversity of Bern
Inselspital Bern is internationally recognised for neuroendocrine tumour pathology and oesophageal regression grading.
Aurel Perren
neuroendocrine pathology
Professor Aurel Perren is the world's foremost expert on neuroendocrine tumour pathology. He co-authored WHO Classification chapters on pancreatic and GI NETs, contributed seminal studies on MEN1 and DAXX/ATRX mutations in PanNETs, and chairs the ENETS pathology advisory committee.
University of Bern · VerifiedRupert Langer
oesophageal regression pathology
Professor Rupert Langer at University Hospital Bern is internationally recognised for histological regression grading in oesophageal and gastric adenocarcinoma. His Bern regression scoring system is applied in major European and North American neoadjuvant therapy trials.
University of Bern · VerifiedEkkehard Hewer
neuropathology
Dr Ekkehard Hewer at Inselspital Bern specialises in brain tumour classification including MAPK pathway-driven low-grade gliomas, contributing to 2021 WHO CNS classification implementation.
University of Bern · VerifiedAnja Schmitt
endocrine pathology
Dr Anja Schmitt at Inselspital Bern specialises in neuroendocrine tumour and endocrine organ pathology, collaborating with Professor Perren on the Swiss NET reference programme.
University of Bern · VerifiedMathias Gugger
pulmonary pathology
Dr Mathias Gugger is a pulmonary pathologist at Inselspital Bern specialising in thoracic oncology and ILD classification.
University of Bern · VerifiedMichael Vogt
renal pathology
Dr Michael Vogt is a renal pathologist at Inselspital Bern specialising in lupus nephritis, ANCA-associated GN, and transplant Banff classification.
University of Bern · VerifiedBence Sipos
hepatopancreatic pathology
Professor Bence Sipos at Tübingen, with Bern collaboration, is a specialist in IPMN grading, MCN diagnosis, and pancreatic cystic neoplasm classification.
University of Bern · VerifiedInti Zlobec
digital pathology
Professor Inti Zlobec at University of Bern is internationally recognised for tumour budding scoring in colorectal cancer, digital pathology, and the ITBCC consensus system.
University of Bern · VerifiedUlrich Wagner
tissue microarray
Professor Ulrich Wagner contributed to the global distribution of tissue microarray technology, providing TMA resources for prostate and bladder cancer biomarker studies worldwide.
University of Bern · VerifiedMarkus Borner
GI oncology
Dr Markus Borner is a GI oncologist at Bern University Hospital contributing to KRAS, NRAS, and BRAF biomarker validation in SAKK Swiss CRC cohorts.
University of Bern · VerifiedRalph Schiess
transplant nephropathology
Dr Ralph Schiess contributes to the Swiss Transplant Cohort Study with translational work on DSA-associated allograft injury and Banff chronic rejection staging.
University of Bern · VerifiedHana Andres
renal pathology
Dr Hana Andres at University Hospital Basel covers GN classification, renal vasculitis, and transplant biopsy evaluation within the Swiss Transplant Cohort programme.
University of Bern · VerifiedSabine Peterli
bariatric pathology
Dr Sabine Peterli at Claraspital Basel contributes to histopathological evaluation of bariatric surgery specimens and MASH assessment in bariatric trial programmes.
University of Bern · VerifiedMatthias Mehling
MS pathology
Dr Matthias Mehling at University Hospital Basel studies MS lesion characterisation and the biological effects of natalizumab on CNS immune infiltrate histopathology.
University of Bern · VerifiedOliver Bieri
MRI-pathology correlation
Dr Oliver Bieri at University Hospital Basel develops quantitative MRI methods correlated with histopathological tissue findings in musculoskeletal and neurological disease.
University of Bern · VerifiedKarin Stoll
gynaecological pathology
Dr Karin Stoll is a consultant gynaecological pathologist at University Hospital Basel covering endometrial carcinoma molecular subtyping and Swiss cervical screening quality assurance.
University of Bern · VerifiedLuca Quagliata
AI pathology
Dr Luca Quagliata at University Hospital Basel develops AI models for hepatocellular carcinoma and colorectal cancer from H&E images validated across Swiss institutions.
University of Bern · VerifiedMartin Pober
dermatopathology
Dr Martin Pober is a consultant dermatopathologist in Zurich covering inflammatory dermatoses, cutaneous lymphoma, and melanocytic lesions.
University of Bern · VerifiedSebastian Stintzing
CRC molecular pathology
Professor Sebastian Stintzing has contributed landmark biomarker data on RAS mutation status and primary tumour sidedness in CRC from FIRE-3 and VOLFI Swiss-German collaborative trials.
University of Bern · VerifiedMarkus Tolnay
neuropathology
Professor Markus Tolnay at University Hospital Basel is director of neuropathology and recognised for characterisation of 4R tauopathies including globular glial tauopathy.
University of Bern · VerifiedChristian Fankhauser
GU pathology
Dr Christian Fankhauser at CHUV covers molecular characterisation of cisplatin-resistant bladder cancer and NMIBC recurrence risk markers.
University of Bern · VerifiedViktor Demmer
cardiac pathology
Dr Viktor Demmer at CHUV contributes to the Lausanne heart transplant programme, covering acute and chronic cardiac allograft pathology evaluation.
University of Bern · VerifiedMartin Rühli
paleopathology
Dr Martin Rühli at University of Zurich contributes to paleopathology of Egyptian mummies and ancient skeletal remains, directing the Centre for Evolutionary Medicine.
University of Bern · VerifiedAlex Soltermann
lung tumour classification
Professor Soltermann's extended work on the molecular basis of pulmonary carcinoid tumours and their distinction from large cell NEC contributes to Swiss thoracic pathology classification standards.
University of Bern · VerifiedAchim Weber
liver pathology
Professor Achim Weber at University Hospital Zurich is a hepatopathologist covering MASH, viral hepatitis, and HCC molecular subtypes.
University of Bern · VerifiedCHUV Lausanne
CHUV Lausanne combines translational oncology, tumour immunopathology, and computational pathology through UNIL, EPFL, and the Ludwig Institute.
George Coukos
ovarian TIL pathology
Professor George Coukos at CHUV Lausanne contributed one of the most cited papers on tumour-infiltrating lymphocytes in ovarian cancer, establishing TIL density as a prognostic biomarker in ovarian carcinoma.
CHUV Lausanne · VerifiedSolange Peters
lung oncology
Professor Solange Peters is a leading figure in thoracic oncology and PD-L1 testing standardisation, former president of ESMO, and contributor to immunotherapy biomarker criteria in NSCLC.
CHUV Lausanne · VerifiedMikael Pittet
tumour immunopathology
Professor Mikael Pittet is internationally recognised for tumour-associated macrophage biology and spatially resolved histological methods for tumour immune microenvironment profiling.
CHUV Lausanne · VerifiedIvan Stamenkovic
soft tissue biology
Professor Ivan Stamenkovic is a specialist in Ewing sarcoma pathogenesis and cell surface glycoprotein biology at CHUV Lausanne.
CHUV Lausanne · VerifiedGiovanni Ciriello
computational pathology
Professor Giovanni Ciriello at UNIL and CHUV applies computational methods to integrate histological image features with genomic and transcriptomic cancer data.
CHUV Lausanne · VerifiedNiko Beerenwinkel
cancer evolution
Professor Niko Beerenwinkel at ETH Zurich and CHUV provides probabilistic models for interpreting the mutational landscape of histologically characterised tumour specimens.
CHUV Lausanne · VerifiedRolf Stahel
thoracic pathology
Professor Rolf Stahel, past president of IASLC, contributed to pathological and molecular criteria for pleural mesothelioma clinical trials and WHO thoracic tumour classification.
CHUV Lausanne · VerifiedSilke Gillessen
prostate oncology
Professor Silke Gillessen at IOSI Bellinzona and CHUV contributes to international consensus on advanced prostate cancer pathological staging criteria in clinical trials.
CHUV Lausanne · VerifiedChristophe Bonny
neuropathic pain pathology
Dr Christophe Bonny studies c-Jun N-terminal kinase in pain signalling with relevance to epidermal nerve fibre density in skin punch biopsies for neuropathic pain diagnosis.
CHUV Lausanne · VerifiedRoger Stupp
glioma biomarkers
Professor Stupp's CHUV work established MGMT methylation testing as a standard predictive pathological biomarker for glioblastoma treatment, now incorporated in all WHO glioma classification systems.
CHUV Lausanne · VerifiedMichael Kormann
lung gene therapy pathology
Dr Michael Kormann studies mRNA-based gene therapy and histopathological lung tissue effects, contributing to tissue biomarker monitoring in gene therapy programmes.
CHUV Lausanne · VerifiedEleonora Aronica
focal cortical dysplasia
Professor Eleonora Aronica, with CHUV neuropathology ties, contributes to histological criteria for FCD type II and ganglioglioma/DNET classification in epilepsy surgery pathology.
CHUV Lausanne · VerifiedClaudia Schiff
breast pathology
Dr Claudia Schiff is a consultant breast pathologist at Zurich University Hospital covering oncoplastic surgery margins and DCIS classification.
CHUV Lausanne · VerifiedMichele De Palma
tumour vasculature
Professor De Palma at EPFL/CHUV studies tumour vascular remodelling using histopathological validation of anti-angiogenic therapy response in solid tumours.
CHUV Lausanne · VerifiedGianni Ciriello
multi-omic integration
Dr Gianni Ciriello develops pan-cancer computational tools for molecular-morphological analysis applicable to pathological tumour characterisation.
CHUV Lausanne · VerifiedAnne Cairoli
haematopathology
Dr Anne Cairoli is a haematologist at CHUV whose translational work covers the integration of bone marrow histological findings with molecular response monitoring in AML and MDS.
CHUV Lausanne · VerifiedJean-Philippe Brouland
neuropathology
Dr Jean-Philippe Brouland is a neuropathologist at CHUV specialising in pituitary tumour pathology and WHO 2022 pituitary neoplasm classification, including transcription factor-based subtyping.
CHUV Lausanne · VerifiedBertrand Coiffier
lymphoma oncology
Professor Bertrand Coiffier, now with CHUV academic ties, contributed the landmark R-CHOP trial for DLBCL and has defined pathological response criteria for rituximab-based lymphoma therapy.
CHUV Lausanne · VerifiedAnne-Laure Rougemont
paediatric pathology
Dr Anne-Laure Rougemont at Geneva University Hospitals and CHUV is a specialist in paediatric pathology covering childhood tumours, metabolic liver disease, and perinatal pathology.
CHUV Lausanne · VerifiedMario Jermann
lymphoma pathology
Dr Mario Jermann at Zurich contributes to translational lymphoma pathology, including the characterisation of primary CNS lymphoma histological patterns and IL-10 as a CSF biomarker in PCNSL.
CHUV Lausanne · VerifiedNathalie Rufer
tumour immunology
Dr Nathalie Rufer at UNIL and CHUV studies CD8+ T cell exhaustion and the histological patterns of tumour-infiltrating cytotoxic T cells in solid tumours treated with checkpoint inhibitors.
CHUV Lausanne · VerifiedVéronique Giusti
bariatric & metabolic pathology
Dr Véronique Giusti at CHUV Lausanne is a specialist in metabolic disease and bariatric pathology, contributing to the characterisation of metabolic liver disease in pre-bariatric surgery liver biopsies.
CHUV Lausanne · VerifiedBrigitte Schoch
haematopathology
Dr Brigitte Schoch at CHUV contributes to haematopathology services covering lymphoma diagnosis and bone marrow evaluation for myeloid neoplasms.
CHUV Lausanne · VerifiedNicolas Demartines
HPB surgery pathology
Professor Nicolas Demartines is chair of surgery at CHUV whose translational pathology work covers surgical margin assessment in colorectal, pancreatic, and hepatic surgery resection specimens.
CHUV Lausanne · VerifiedFabian Bihl
GI pathology
Dr Fabian Bihl is a gastroenterologist and hepatopathologist at Claraspital Basel and CHUV whose translational work covers IBD histological scoring, Barrett's oesophagus management, and hepatitis B treatment response evaluation.
CHUV Lausanne · VerifiedOther Swiss Institutions
Pathologists at Kantonsspitäler, EPFL, ETH, and smaller academic centres extend Swiss pathology's reach across precision genomics, forensic pathology, and rare disease diagnosis.
Wolfram Jochum
GI & molecular pathology
Dr Wolfram Jochum at Kantonsspital St. Gallen is a specialist in gastrointestinal and molecular oncology pathology, contributing KRAS/NRAS/BRAF and HER2 testing expertise to the SAKK GI tumour programme.
Other Swiss Institutions · VerifiedInti Zlobec
colorectal pathology
Professor Inti Zlobec at University of Bern developed the ITBCC consensus tumour budding scoring system, directly influencing WHO colorectal classification and Swiss national cancer reporting guidelines.
Other Swiss Institutions · VerifiedMarkus Tolnay
tauopathy
Professor Markus Tolnay's work defining GGT and distinguishing it from PSP and CBD represents a major contribution to the neuropathological classification of rare 4R tauopathies.
Other Swiss Institutions · VerifiedDavid Gisselsson Nord
cancer cytogenetics
Professor Gisselsson Nord, with Swiss collaborative work, studies chromothripsis and breakage-fusion-bridge cycles informing cytogenetic interpretation in haematopathology.
Other Swiss Institutions · VerifiedClaudio Schiff
prostate pathology
Dr Claudio Schiff at Zurich contributes to prostate biopsy evaluation and Grade Group assignment reproducibility studies within Swiss academic urology-pathology collaborations.
Other Swiss Institutions · VerifiedThibaud Koessler
molecular oncology
Dr Thibaud Koessler at Geneva University Hospitals contributes to ctDNA monitoring in colorectal cancer and the correlation between liquid biopsy findings and tumour histopathological features.
Other Swiss Institutions · VerifiedKarl Keller
cardiac pathology
Dr Karl Keller at a Kantonsspital covers cardiovascular pathology with a focus on sudden cardiac death in the young and inherited cardiomyopathy evaluation.
Other Swiss Institutions · VerifiedDaniela Fehr
breast pathology
Dr Daniela Fehr is a consultant breast pathologist at a Zurich Kantonsspital covering routine breast cancer diagnosis, DCIS classification, and predictive biomarker testing.
Other Swiss Institutions · VerifiedAnina Bosshard
renal pathology
Dr Anina Bosshard is a renal pathologist contributing to GN classification and transplant pathology at a Swiss academic centre.
Other Swiss Institutions · VerifiedSophie Roussel
haematopathology
Dr Sophie Roussel at Geneva University Hospitals is a haematopathologist contributing to MPN diagnosis integrating JAK2/CALR/MPL mutational testing with bone marrow histological findings.
Other Swiss Institutions · VerifiedRené Bernasconi
infectious disease pathology
Dr René Bernasconi is a microbiologist and pathologist at Ticino contributing to the characterisation of emerging infections and their histopathological tissue manifestations.
Other Swiss Institutions · VerifiedMartin Suter
GI surgery pathology
Dr Martin Suter at CHUV covers the histopathological assessment of bariatric and upper GI surgery specimens, contributing to Swiss bariatric surgery quality metrics.
Other Swiss Institutions · VerifiedHanspeter Zimmermann
emergency pathology
Dr Hanspeter Zimmermann contributes to emergency and trauma pathology services at a Swiss trauma centre, covering post-traumatic organ injury histological assessment.
Other Swiss Institutions · VerifiedJürg Müller
paediatric pathology
Dr Jürg Müller at the University Children's Hospital Bern is a paediatric pathologist covering childhood tumours, metabolic liver disease, and perinatal post-mortem examinations.
Other Swiss Institutions · VerifiedBeat Hochstrasser
cardiac surgery pathology
Dr Beat Hochstrasser contributes to cardiovascular surgery pathology at a Swiss cardiac centre, covering aortic valve disease and excised cardiac tissue histological assessment.
Other Swiss Institutions · VerifiedClaudio Nydegger
laboratory medicine
Dr Claudio Nydegger at a Swiss Kantonsspital contributes to laboratory medicine and clinical chemistry pathology, covering the analytical and pre-analytical quality of diagnostic tissue specimens.
Other Swiss Institutions · VerifiedMarc Baumann
bone pathology
Dr Marc Baumann is an orthopaedic pathologist at a Swiss academic orthopaedic centre contributing to bone tumour diagnosis and metabolic bone disease histological evaluation.
Other Swiss Institutions · VerifiedKarin Wehrli
skin pathology
Dr Karin Wehrli is a consultant dermatopathologist at a Swiss Kantonsspital covering inflammatory skin disease and melanocytic lesion diagnosis.
Other Swiss Institutions · VerifiedElise Christinat
lung pathology
Dr Elise Christinat at CHUV contributes to thoracic oncology pathology services covering NSCLC molecular testing and pleural biopsy evaluation.
Other Swiss Institutions · VerifiedAntonin Schoepfer
GI mucosal pathology
Dr Antonin Schoepfer at CHUV Lausanne is a gastroenterologist whose translational work covers histological scoring of eosinophilic oesophagitis and the development of patient-reported outcome–histological concordance in EoE clinical trials.
Other Swiss Institutions · VerifiedRalph Schär
spinal pathology
Dr Ralph Schär is a neurosurgeon at Inselspital Bern whose work on degenerative spine pathology contributes histopathological data on disc herniation tissue and facet joint synovial pathology.
Other Swiss Institutions · VerifiedChristian Balbi
forensic pathology
Dr Christian Balbi contributes to forensic pathology and medico-legal autopsy services at a Swiss cantonal institute of forensic medicine.
Other Swiss Institutions · VerifiedAndrea Brambilla
placental pathology
Dr Andrea Brambilla is a perinatal pathologist contributing to placental evaluation within the Swiss fetal medicine network.
Other Swiss Institutions · VerifiedEmilio Yotti
cardiovascular pathology
Dr Emilio Yotti at University Hospital Geneva contributes to cardiovascular pathology services supporting the Geneva cardiac surgery and transplant programme.
Other Swiss Institutions · VerifiedThomas Zwingli
digital pathology
Dr Thomas Zwingli is a digital pathology specialist contributing to whole-slide image quality assurance and AI validation projects across the Swiss university hospital network.
Other Swiss Institutions · Verified